Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine

British Journal of Anaesthesia

Volumn 77, Issue 4, 1996, Pages 492-495

  Fleming, N W ^a   Macres, S ^a   Antognini, J F ^a   Vengco, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antagonists neuromuscular block, edrophonium; Antagonists neuromuscular block, neostigmine; Antagonists neuromuscular block, pyridostigmine; Enzymes, cholinesterase; Neuromuscular block, suxamethonium

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; EDROPHONIUM; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; PYRIDOSTIGMINE; SUFENTANIL; SUXAMETHONIUM; VECURONIUM;

ADULT; AGED; ARTICLE; CHOLINESTERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029797877     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.4.492     Document Type: Article

References (17)

1. Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. Anesthesiology 1992; 77: 785-805.
2. Sunew KY, Hicks RG. Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity. Anesthesiology 1978; 49: 188-191.
3. Bishop MJ, Hornbein TF. Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure. Anesthesiology 1983; 58: 384-386.
4. McCoy EP, Mirakhur RK. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium. Acta Anaesthesiologica Scandinavica 1995; 39: 744-747.
5. Sohn YJ, Cronnelly R, Sharma M. Is the duration of action of succinylcholine prolonged following antagonism of neuromuscular blockade by edrophonium? Anesthesiology 1984; 61: A302.
6. Valdrighi JB, Fleming NW, Smith BK, Baker GL, White DA. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium. British Journal of Anaesthesia 1994; 72: 237-239.
7. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961; 7: 88-95.
8. Viby-Mogensen J. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with genotypically normal enzyme. Anesthesiology 1980; 53: 517-520.
9. Mirakhur RK. Edrophonium and plasma cholinesterase activity. Canadian Journal of Anaesthesia 1986; 33: 588-590.
10. Bowman WC. Pharmacology of Neuromuscular Function, 2nd Edn. London: Wright, 1990; 179-180.
11. Hoppe JO. Observations on the potency of neuromuscular blocking agents with particular reference to succinylcholine. Anesthesiology 1955; 16: 91-124.
12. Willis JH. The measurement and significance of changes in the cholinesterase activities of erythrocytes and plasma in man and animals. Critical Reviews in Toxicology 1972; 1: 153-202.
13. Ecobichon DJ, Comean AM. Pseudocholinesterases of mammalian plasma: physicochemical properties and organophosphate inhibition in eleven species. Toxicology and Applied Pharmacology 1973; 24: 92-100.
14. Rao PS, Roberts GH, Pope CN, Ferguson PW. Comparative inhibition of rodent and human erythrocyte acetylcholinesterase by carbofuran and carbaryl. Pesticide Biochemistry and Physiology 1994; 48: 79-84.
15. Baraka A, Wakid N, Mansour R, Haddad W. Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity. British Journal of Anaesthesia 1981; 53: 849-851.
16. Mirakhur RK, Lavery TD, Briggs LP, Clarke RSJ. Effects of neostigmine and pyridostigmine on serum cholinesterase activity. Canadian Journal of Anaesthesia 1982; 29: 55-58.
17. Naquib M, Selim M, Bakhamees H, Samarkandi AH, Turkistani A. Enzymatic versus pharmacologic antagonism of profound mivacurium-induced neuromuscular blockade. Anesthesiology 1996; 84: 1051-1059.